Drug vectorization

In pharmacology and medicine vectorization of drugs refers to (intracellular) targeting with plastic, noble metal or silicon nanoparticles or liposomes to which pharmacologically active substances are reversibly bound or attached by adsorption.^[1]^[2]

CNRS researchers have devised a way to overcome the problem of multidrug resistance using polyalkylcyanoacrylate (PACA) nanoparticles as "vectors".^[3]

Drug nanocarriers are expected to play a major role in delivering multiple drugs to tumor tissues by overcoming biological barriers.^[4]

References

^ Couvreur P. (2001). "Drug vectorization or how to modulate tissular and cellular distribution of biologically active compounds". Ann Pharm Fr. 59 (4): 232–8. PMID 11468577.
^ Secret, Emilie; Smith, Kevin; Dubljevic, Valentina; Moore, Eli; Macardle, Peter; et al. (2012-11-30). "Antibody-Functionalized Porous Silicon Nanoparticles for Vectorization of Hydrophobic Drugs". Advanced Healthcare Materials. 2 (5). Wiley: 718–727. doi:10.1002/adhm.201200335. ISSN 2192-2640. PMID 23203914.
^ "Archived copy". Archived from the original on 2015-07-19. Retrieved 2016-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
^ "Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment". Nanomedicine (Lond.). 9 (10): 1499–515. 2014. doi:10.2217/nnm.14.97. PMID 25253498.